Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses.

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it.

Prime Minister Narendra Modi on Thursday hailed the completion of the Genome India Project as a historic milestone in the ...

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

The study also evaluated the effectiveness of public health measures, such as travel restrictions, in reducing the spread ...

despite the challenges posed by the Covid-19 pandemic. More than 20 research institutions such as IISc, IITs, CSIR and ...

The Genome India project, a major initiative to map India's genetic diversity, has been completed. This milestone promises advancements in personalised medicine and disease understanding ...

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells ...

The Health sector expects the Finance Minister to prioritise healthcare in the upcoming Budget while the country works to ...

Five years ago, the Genome India Project was approved. Despite the challenges posed by Covid-19 during this period, our scientists have worked tirelessly to complete this project. The genomic data ...